LAG3 and esophageal squamous cell carcinoma: Given LAG3's unique characteristics compared to other co-inhibitory receptors, we specifically examined its potential as a predictive biomarker and local immunomodulatory factor in TME, with the goal of refining therapeutic strategies and improving outcomes for locally advanced ESCC patients.